Used as a key chiral intermediate in the synthesis of fluorinated pharmaceutical compounds, particularly in the development of selective enzyme inhibitors. Its structure supports high enantioselectivity, making it valuable in creating active pharmaceutical ingredients (APIs) with improved metabolic stability and target specificity. Commonly employed in the production of central nervous system (CNS) agents and antiviral drugs where fluorine substitution enhances blood-brain barrier penetration and bioavailability.